Exceeding Expectations
Since 1991

CPL has a reputation as one of the most service-oriented contract manufacturers in the pharmaceutical industry.

2005

CPL acquired the Buffalo Site from Bristol-Myers Squibb, expanding capability and capacity to better serve our global customers. The 415,000 sq. ft. facility has a rich history, dating over 100 years as experts in liquid and semi-solid dosage forms.

Clearly a strategic fit, the site, the company's first in the United States, offers redundancy in key areas of liquid and semi-solid manufacturing including, among others, explosion-proof and light-sensitive production. In addition, the acquisition broadens our service offering to include applicators, state-of-the-art pilot facilities, high speed large volume filling, and injection blow molding and decorating of bottles and jars.

With a staff of over 200 and over 200 SKUs (more than 20 NDAs), the FDA, HPFBI, MHRA, DEA, and ISO 14001 compliant operation represents a tremendous addition to help ensure CPL can continue to support customers as we continue to grow.

 

2004

CPL launched lean manufacturing - an initiative focused on stream-lining processes to improve efficiencies and reduce waste.

CPL acquired a new Enflex F-11 Sachet filler (1g-15g) for liquids and semi-solids.

CPL expanded vacuum manufacturing capabilities with the acquisition of a 5,000 liter vacuum vessel.

CPL launched a new liquid solution and suspension manufacturing suite with state-of-the-art cGMP design, HEPA filtration and a maximum batch size of 5,000 liters. The manufacturing suite is fully integrated with a new liquid filling line.

 

2003

CPL launched a new manufacturing suite increasing the largest batch size to 8,000 Kg.

CPL acquired fully integrated, high speed, high volume lotion/cream filling line.

CPL acquires Innopharm, a full service testing laboratory (cGMP compliant and FDA and Health Canada inspected) with a reputation for providing quality services while adhering to aggressive timelines. The strategic acquisition of Innopharm further enhances CPL's ability to provide flexible, quality, customer focused services.

 

2002

CPL implements a Process Excellence program based on the Six Sigma methodology -a process designed to improve process reliability to maximize service to customers. The process resulted in reduced lead times, enhanced delivery performance and stronger customer relationships.

 

2001

CPL acquires the remainder of the Danbro facility increasing the manufacturing and packaging facility to 140,000 square feet.

 

2000

Shipping into the United States since 1996, CPL received its first FDA PAI ANDA inspection.

 

1999

CPL goes live on SAP. The implementation of SAP stemmed from a proactive investment to support electronic transactions with customers.

 

1997

CPL acquires 85,000 square foot Danbro facility in partnership with Block Drug. In addition to added capacity, the acquisition of the facility launched CPL into explosion proof manufacturing.

 

1993

CPL expands into its Kitimat facility, a 59,000 square foot production plant in Mississauga, Ontario.

 

1991

CPL is founded as a third party packaging contractor.

 

Providing Innovative Leadership in the Liquid and Semi-Solid Market since 1991.